002932.SZ
*ST明德
SZSE · Healthcare · C 制造业 · CN
CNY 15.18
−0.52%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 265.8M | 265.1M | 350.1M | 749.5M | 10.5B |
| Cost of Revenue | 145.8M | 169.2M | 161.4M | 342.7M | 3.5B |
| Gross Profit | 120.0M | 95.9M | 188.7M | 406.8M | 7.0B |
| Operating Expenses | |||||
| R&D Expense | 78.0M | 85.8M | 109.6M | 141.4M | 388.4M |
| SG&A Expense | — | — | — | — | — |
| General & Admin Expense | 65.2M | 67.0M | 84.3M | 112.6M | 142.0M |
| Selling & Marketing Expense | 71.0M | 73.7M | 85.3M | 115.9M | 450.8M |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 220.6M | 229.3M | 271.1M | 377.4M | 1.0B |
| Cost and Expenses | 366.5M | 398.5M | 432.5M | 720.1M | 4.5B |
| Operating Income (EBIT) | (74.2M) | (78.4M) | 41.2M | 145.2M | 5.1B |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Net Interest Income | — | — | — | — | — |
| Other Non-Op Income/Expense | — | — | — | — | — |
| Non-Operating Income (excl Interest) | — | — | — | — | — |
| EBT (Pre-Tax Income) | (57.3M) | (63.8M) | 32.4M | 139.9M | 5.1B |
| Income Tax Expense | 12.6M | 11.3M | 5.9M | 70.7M | 695.8M |
| Bottom Line | |||||
| Net Income | (13.2M) | (16.5M) | 74.5M | 74.9M | 4.2B |
| Earnings from Cont. Ops | (69.9M) | (75.1M) | 26.6M | 69.2M | 4.4B |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (13.2M) | (16.5M) | 74.5M | 74.9M | 4.2B |
| Per Share | |||||
| Basic EPS | (CN¥0.05) | (CN¥0.07) | CN¥0.33 | CN¥0.33 | CN¥18.46 |
| Diluted EPS | (CN¥0.05) | (CN¥0.07) | CN¥0.33 | CN¥0.33 | CN¥18.31 |
| Revenue Per Share | — | CN¥1.13 | CN¥1.55 | CN¥3.30 | CN¥46.19 |
| Shares | |||||
| Basic Shares Outstanding | — | 235.2M | 225.8M | 227.0M | 228.0M |
| Diluted Shares Outstanding | — | 235.2M | 225.8M | 227.0M | 228.0M |
| Profitability Metrics | |||||
| EBITDA | — | (25.7M) | 112.7M | 223.4M | 5.1B |
| D&A | — | 52.7M | 71.6M | 78.2M | 47.7M |
| EBIT | — | — | — | — | — |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026